Skip to content

Oncoteq

About Us
+
Pipeline
Platform
Investors & Media
News
Contact

TEQ102

TEQ102

Target

Target

CD30

Indication

Indication

CD30+ Lymphomas

Preclinical

Phase 1

Phase 2

Phase 3

Start
Pipeline
TEQ102

About Oncoteq

About Us
Management
Board of Directors
Advisors

Pipeline, Platform & Investors

Platform
Pipeline

Investors & Media

Investors & Media

Contact us

Oncoteq AG
Maschinengasse 10
6330 Cham
Switzerland

CHE 234.928.941

info@oncoteq.ch
ir@oncoteq.ch

Follow us

Follow us on linkedin.com

Oncoteq is a clinical stage, oncology focused biotechnology company leveraging artificial intelligence (AI).

© Copyright 2023 - Oncoteq AG | All Rights Reserved | Privacy policy | Impressum | Cookie settings

Video

Cookies

We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings".

Settings Accept all

Cookies

Choose what kind of cookies to accept. Your choice will be saved for one year.

Necessary
These cookies are not optional. They are needed for the website to function.
Statistics
In order for us to improve the website's functionality and structure, based on how the website is used.
Experience
In order for our website to perform as well as possible during your visit. If you refuse these cookies, some functionality will disappear from the website.
Marketing
By sharing your interests and behavior as you visit our site, you increase the chance of seeing personalized content and offers.

Save Accept all